SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
-1.58%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$2.14B
AUM Growth
+$2.14B
(+49%)
Cap. Flow
+$729M
Cap. Flow
% of AUM
34.01%
Top 10 Holdings %
Top 10 Hldgs %
90.45%
Holding
108
New
16
Increased
40
Reduced
26
Closed
13
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$488M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$121M |
| 3 |
Simplify Multi-QIS Alternative ETF
QIS
|
$90M |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
$89.1M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$71.9M |
Top Sells
| 1 |
Simplify Stable Income ETF
BUCK
|
$109M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$25.3M |
| 3 |
DexCom
DXCM
|
$5.91M |
| 4 |
Edwards Lifesciences
EW
|
$5.14M |
| 5 |
Akero Therapeutics
AKRO
|
$4.82M |
Sector Composition
| 1 | Healthcare | 7.09% |
| 2 | Energy | 1.27% |
| 3 | Real Estate | 0.5% |
| 4 | Industrials | 0.18% |
| 5 | Consumer Discretionary | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avidity Biosciences
RNA
$5.99B
| $3.69M | 0.14% |
125,000
| – | – |
|
27
PureCycle Technologies
PCT
$2.57B
| $3.53M | 0.13% |
510,086
-651,122
| -56% | -$4.51M |
|
28
Quest Diagnostics
DGX
$20.3B
| $3.5M | 0.13% |
+20,671
| New | +$3.5M |
|
29
Tesla
TSLA
$1.08T
| $3.34M | 0.13% |
12,904
+373
| +3% | +$96.7K |
|
30
Pacira BioSciences
PCRX
$1.2B
| $3.33M | 0.12% |
134,042
+96,300
| +255% | +$2.39M |
|
31
AGNC Investment
AGNC
$10.2B
| $3.08M | 0.12% |
321,550
+178,000
| +124% | +$1.71M |
|
32
Philip Morris
PM
$260B
| $2.93M | 0.11% |
+18,480
| New | +$2.93M |
|
33
VanEck Bitcoin Trust
HODL
$1.64B
| $2.83M | 0.11% |
+121,480
| New | +$2.83M |
|
34
AstraZeneca
AZN
$248B
| $2.65M | 0.1% |
+35,990
| New | +$2.65M |
|
35
Alignment Healthcare
ALHC
$3.24B
| $2.49M | 0.09% |
133,466
+692
| +0.5% | +$12.9K |
|
36
ResMed
RMD
$40.2B
| $2.48M | 0.09% |
11,101
-19,040
| -63% | -$4.26M |
|
37
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $2.44M | 0.09% |
23,346
+4,066
| +21% | +$425K |
|
38
Gilead Sciences
GILD
$140B
| $2.38M | 0.09% |
21,272
-24,895
| -54% | -$2.79M |
|
39
Direxion Daily TSLA Bull 2X Shares
TSLL
$5.76B
| $2.34M | 0.09% |
245,408
+63,286
| +35% | +$602K |
|
40
Sanofi
SNY
$121B
| $2.25M | 0.08% |
40,597
+210
| +0.5% | +$11.6K |
|
41
Neurocrine Biosciences
NBIX
$13.8B
| $2.24M | 0.08% |
+20,274
| New | +$2.24M |
|
42
Applied Therapeutics
APLT
$71M
| $2.19M | 0.08% |
4,487,505
+1,670,000
| +59% | +$816K |
|
43
Rithm Capital
RITM
$6.57B
| $2.18M | 0.08% |
190,780
+15,000
| +9% | +$172K |
|
44
Annaly Capital Management
NLY
$13.6B
| $2.14M | 0.08% |
105,190
+24,916
| +31% | +$506K |
|
45
Simplify Commodities Strategy No K-1 ETF
HARD
$33.8M
| $2.08M | 0.08% |
+66,957
| New | +$2.08M |
|
|
RFIX
46
Simplify Bond Bull ETF
RFIX
$122M
| $2M | 0.07% |
+37,400
| New | +$2M |
|
47
Simplify Managed Futures Strategy ETF
CTA
$1.15B
| $1.98M | 0.07% |
66,957
-73,421
| -52% | -$2.17M |
|
48
Abeona Therapeutics
ABEO
$350M
| $1.94M | 0.07% |
408,584
| – | – |
|
|
SCY
49
DELISTED
Simplify US Small Cap PLUS Income ETF
SCY
| $1.86M | 0.07% |
+95,000
| New | +$1.86M |
|
50
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.82M | 0.07% |
147,785
+144
| +0.1% | +$1.77K |
|